DDIT3 and neuroblastoma: Specifically, overexpression of a negative dominant form of PKR (K296R) on neuroblastoma cells inhibits pharmacological ER stress (induced with tunicamycin) and the induction of the apoptotic markers caspase-3 and C/EBP homologous protein (CHOP, also known as GADD153).